Serum multi-biomarkers for predicting relapse in patients with depressive disorders under psychopharmacotherapy
The application of a combined multi-serum biomarker panel could significantly enhance the predictability of depression relapse. Further validation of these biomarkers in diverse populations and settings is warranted to confirm their utility in clinical practice.
Authors
- Min Jhon (ORCID: https://orcid.org/0000-0002-0408-768X)
- Jae‐Min Kim (ORCID: https://orcid.org/0000-0001-7409-6306)
- Il‐Seon Shin (ORCID: https://orcid.org/0000-0001-5370-7649)
- Min‐Gon Kim (ORCID: https://orcid.org/0000-0002-3525-0048)
- Hee‐Ju Kang (ORCID: https://orcid.org/0000-0002-4784-4820)
- Sung‐Wan Kim (ORCID: https://orcid.org/0000-0002-6739-2163)
- Ju‐Yeon Lee (ORCID: https://orcid.org/0000-0003-0653-7223)
Institutions
- Chonnam National University (KR)
- Gwangju Institute of Science and Technology (KR)
- Chonnam National University Hospital (KR)
Publication Details
- Journal
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.pnpbp.2025.111360
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00